|
Volumn 56, Issue 1, 2002, Pages 43-49
|
BCL-2 family proteins modulate radiosensitivity in human malignant glioma cells
a a a a a a |
Author keywords
BAX; BCL 2; Cell cycle; Glioma; Radiotherapy
|
Indexed keywords
DOXORUBICIN;
GYRASE INHIBITOR;
PROTEIN BAK;
PROTEIN BAX;
PROTEIN BCL 2;
PROTEIN BCL XL;
PROTEIN MCL 1;
TENIPOSIDE;
ARTICLE;
CANCER CELL CULTURE;
CANCER RADIOTHERAPY;
CANCER RESISTANCE;
CELL CYCLE;
CHEMOSENSITIVITY;
CLINICAL TRIAL;
CORRELATION ANALYSIS;
DRUG SENSITIVITY;
GAMMA IRRADIATION;
GENE EXPRESSION;
GLIOBLASTOMA;
GLIOMA CELL;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
MALIGNANT NEOPLASTIC DISEASE;
PREDICTION;
PROTEIN EXPRESSION;
RADIOSENSITIVITY;
TRANSGENE;
ANTINEOPLASTIC AGENTS;
BCL-2-ASSOCIATED X PROTEIN;
BRAIN NEOPLASMS;
CELL CYCLE;
DOSE-RESPONSE RELATIONSHIP, RADIATION;
GENE EXPRESSION REGULATION, NEOPLASTIC;
GENE TRANSFER TECHNIQUES;
GLIOMA;
HUMANS;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS C-BCL-2;
TUMOR CELLS, CULTURED;
|
EID: 0036210180
PISSN: 0167594X
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1014448721327 Document Type: Article |
Times cited : (55)
|
References (17)
|